• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性血管扩张剂挑战反应与肺动脉高压性心力衰竭预后的关系。

Nonresponse to Acute Vasodilator Challenge and Prognosis in Heart Failure With Pulmonary Hypertension.

机构信息

Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Cardio Thoraco Vascular Department (DICATOV), IRCCS Policlinico San Martino di Genova, Genova, Italy.

出版信息

J Card Fail. 2021 Aug;27(8):869-876. doi: 10.1016/j.cardfail.2021.01.021. Epub 2021 Feb 5.

DOI:10.1016/j.cardfail.2021.01.021
PMID:33556547
Abstract

BACKGROUND

An acute vasodilator challenge is recommended in patients with heart failure and pulmonary hypertension during heart transplant evaluation. The aim of the study was to assess which hemodynamic parameters are associated with nonresponsiveness to the challenge.

METHODS AND RESULTS

This study is a retrospective analysis of 402 patients with heart failure with pulmonary hypertension who underwent right heart catheterization and a pulmonary vasodilator challenge. Among the 140 who fulfilled the transplant guidelines eligibility criteria for the vasodilator challenge, 38 were responders and 102 nonresponders. At multivariable analysis, a diastolic blood pressure of <70 mm Hg, pulmonary vascular resistance of >5 Woods units, and pulmonary artery compliance of <1.2 mL/mm Hg were independently associated with poor response to vasodilator challenge (all P < .001). The presence of any 2 of these 3 conditions was associated with a 90% probability of being a nonresponder. The covariate-adjusted hemodynamic predictors of death in the entire population were a low baseline systolic blood pressure (P = .0017) and a low baseline right ventricular stroke work index (P = .0395).

CONCLUSIONS

In patients with heart failure and pulmonary hypertension, low pulmonary arterial compliance, high pulmonary vascular resistance, and low diastolic blood pressure predict the nonresponsiveness to acute vasodilator challenge whilst a poor right ventricular function predicts a dismal prognosis.

摘要

背景

在心脏移植评估期间,建议心力衰竭和肺动脉高压患者进行急性血管扩张剂挑战。本研究旨在评估哪些血流动力学参数与对该挑战无反应相关。

方法和结果

这是一项对 402 例患有心力衰竭合并肺动脉高压并接受右心导管检查和肺动脉扩张剂挑战的患者进行的回顾性分析。在符合血管扩张剂挑战移植指南标准的 140 名患者中,有 38 名是有反应者,102 名是非有反应者。多变量分析显示,舒张压<70mmHg、肺血管阻力>5 伍兹单位和肺动脉顺应性<1.2mL/mm Hg 与对血管扩张剂挑战反应不佳独立相关(均 P<.001)。这 3 个条件中的任何 2 个存在与 90%的非反应者可能性相关。整个人群中,死亡的协变量调整后血流动力学预测因素为低基线收缩压(P=.0017)和低基线右心室每搏功指数(P=.0395)。

结论

在心力衰竭和肺动脉高压患者中,低肺动脉顺应性、高肺血管阻力和低舒张压预测急性血管扩张剂挑战无反应,而右心室功能不良预测预后不良。

相似文献

1
Nonresponse to Acute Vasodilator Challenge and Prognosis in Heart Failure With Pulmonary Hypertension.急性血管扩张剂挑战反应与肺动脉高压性心力衰竭预后的关系。
J Card Fail. 2021 Aug;27(8):869-876. doi: 10.1016/j.cardfail.2021.01.021. Epub 2021 Feb 5.
2
Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications.硝普钠治疗混合性肺动脉高压合并左心疾病患者:反应的血流动力学预测因子和预后意义。
J Card Fail. 2016 Feb;22(2):117-24. doi: 10.1016/j.cardfail.2015.10.018. Epub 2015 Nov 4.
3
Right-heart function related to the results of acute pulmonary vasodilator testing in patients with pulmonary arterial hypertension caused by connective tissue disease.右心功能与结缔组织病相关性肺动脉高压患者急性肺血管扩张试验结果的关系。
J Am Soc Echocardiogr. 2012 Mar;25(3):274-9. doi: 10.1016/j.echo.2011.11.007. Epub 2011 Dec 3.
4
Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.肺血管扩张性可预测心力衰竭患者的肺动脉高压严重程度、运动能力及生存率。
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.003011.
5
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.右心室对急性肺血管扩张的反应可预测晚期心力衰竭和肺动脉高压患者的预后。
Am Heart J. 2003 Feb;145(2):310-6. doi: 10.1067/mhj.2003.146.
6
Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.心力衰竭相关肺动脉高压。流行病学、右心室功能与生存。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1234-46. doi: 10.1164/rccm.201503-0529OC.
7
Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.在评估心脏移植候选者时,用舒张压差异来分类肺动脉高压。
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.004077.
8
Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure.慢性心力衰竭患者肺动脉高压的有创和无创决定因素
J Heart Lung Transplant. 2000 May;19(5):426-38. doi: 10.1016/s1053-2498(00)00084-x.
9
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.心力衰竭伴射血分数降低和不同形式毛细血管后性肺动脉高压患者急性血管扩张剂挑战的血液动力学效应。
Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16.
10
Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices.连续血流左心室辅助装置对移植前和移植后肺血液动力学的影响。
J Thorac Cardiovasc Surg. 2010 Aug;140(2):447-52. doi: 10.1016/j.jtcvs.2010.03.006.

引用本文的文献

1
Pulmonary hypertension associated with left heart disease.与左心疾病相关的肺动脉高压。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01344-2024. Print 2024 Oct.
2
Clinical Applications of Pressure-Volume Assessment in Congenital Heart Disease.压力-容积评估在先天性心脏病中的临床应用
J Soc Cardiovasc Angiogr Interv. 2023 Feb 22;2(3):100599. doi: 10.1016/j.jscai.2023.100599. eCollection 2023 May-Jun.
3
Contemporary Evidence and Practice on Right Heart Catheterization in Patients with Acute or Chronic Heart Failure.
急性或慢性心力衰竭患者右心导管检查的当代证据与实践
Diagnostics (Basel). 2024 Jan 7;14(2):136. doi: 10.3390/diagnostics14020136.
4
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction.左心疾病中的右心衰竭:右心室功能障碍的影像学、功能和生化方面。
Heart Fail Rev. 2023 Jul;28(4):1009-1022. doi: 10.1007/s10741-022-10276-0. Epub 2022 Nov 16.